Recruitment

Recruitment Status
Completed

Summary

Conditions
Chronic Obstructive Pulmonary Disease - COPD
Type
Interventional
Phase
Phase 2
Design
Allocation: RandomizedIntervention Model: Crossover AssignmentMasking: Triple (Participant, Investigator, Outcomes Assessor)Primary Purpose: Treatment

Participation Requirements

Age
Between 40 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01551888
Collaborators
Not Provided
Investigators
Study Director: Esther Garcia, MD AstraZeneca